Hepatitis B virus (HBV) infection constitutes a global public health problem. In order to establish how HBV was disseminated across different geographic regions, we estimated the levels of regional clustering for genotypes D and A. We used 916 HBV-D and 493 HBV-A full-length sequences to reconstruct their global phylogeny. Phylogeographic analysis was conducted by the reconstruction of ancestral states using the criterion of parsimony. The putative origin of genotype D was in North Africa/Middle East. HBV-D sequences form low levels of regional clustering for the Middle East and Southern Europe. In contrast, HBV-A sequences form two major clusters, the first including sequences mostly from sub-Saharan Africa, and the second including sequences mostly from Western and Central Europe. Conclusion: We observed considerable differences in the global dissemination patterns of HBV-D and HBV-A and different levels of monophyletic clustering in relation to the regions of prevalence of each genotype.

Background/Objectives: Endogenous metabolic pathways periodically adjust with fluctuations in day and night, a biological process known as circadian rhythm. Time-restricted eating (TRE) aligns the time of food intake with the circadian rhythm. This study aims to investigate the effects of TRE on body weight, body composition and cardiometabolic risk factors. Methods: We reviewed articles from PubMed and Cochrane libraries for clinical trials that compare TRE with regular diet without calorie restriction. We conducted a meta-analysis of 26 studies. Results: Participants who followed TRE demonstrated reduction in body weight [mean-MD: −1.622 kg, (95% confidence interval (CI −2.302 to −0.941)], body mass index (BMI) [MD: −0.919 kg/m² (95% CI: −1.189 to −0.650)], waist circumference [MD: −2.015 cm (95% CI: −3.212 to −0.819] and whole-body fat mass (WBFM) [MD: −0.662 kg (95% CI: −0.795 to −0.530)]. Improvements in cardiometabolic risk factors such as a decrease in insulin concentrations [MD: −0.458 mIU/L, (95% CI: −0.843 to −0.073)], total cholesterol [MD: −2.889 mg/dL (95% CI: −5.447 to −0.330) and LDL concentrations [MD: −2.717 mg/dL (95% CI: −4.412 to −1.021)] were observed. Conclusions: TRE is beneficial for weight loss and improvements in cardiometabolic risk factors. Further large-scale clinical trials are needed to confirm these findings.

Cardiovascular disease is commonly accompanied by renal dysfunction. Multimorbidity in hospitalized patients impacts unfavorably on prognosis and hospital stay. We aimed to illustrate the contemporary burden of cardiorenal morbidity across inpatient cardiology care in Greece. The Hellenic Cardiorenal Morbidity Snapshot (HECMOS) used an electronic platform to collect demographic and clinically relevant information about all patients hospitalized on the 3^rd of March 2022 in Greece. The participating institutions covered all levels of inpatient cardiology care and most of the country's territories in order to collect a real-world, nation representative sample. 923 patients (males 68.4%, median age 73ys ± 14.8) were admitted in 55 different cardiology departments. 57.7% of the sample were older than 70 years of age. Hypertension was highly prevalent, present in 66% of cases. History of chronic HF, DM, AF and CKD was present in 38%, 31.8%, 30% and 26% respectively. 64.1% of the sample exhibited at least one of these four entities. Accordingly, a combination of at least 2 of them was recorded in 38.7%, of at least three in 18.2% whereas 4.3% of the sample combined all four morbid conditions in their past medical history. The most common combination was the coexistence of HF-AF accounting for 20.6% of the sample. 9 out of 10 non-electively admitted patients were hospitalized due to acute HF (39.9%), ACS (33.5%) or tachyarrhythmias (13.2%). HECMOS participants carried a remarkable burden of cardio-reno-metabolic disease. HF in conjunction with AF were found to be the most prevalent combination among the studied cardiorenal nexus of morbidities in the whole study population.

Obesity is a critical public health issue, necessitating effective weight loss interventions. While various dietary regimens have been explored, individual responses to interventions often vary. This study involved a 3-month dietary intervention aiming at assessing the role of macronutrient composition and the potential role of genetic predisposition in weight loss among Greek adults. This randomized clinical trial followed the CONSORT principles, recruiting 202 participants overall; 94 received a hypocaloric, high-protein diet and 108 received a high-carbohydrate, hypocaloric diet. Genetic predispositions were assessed through 10 target variants known for their BMI associations. Participants’ weight and BMI values were recorded at baseline and post-intervention (n = 202 at baseline, n = 84 post-intervention) and an imputation method was applied to account for the observed missing values. Participants experienced a statistically significant weight loss across all dietary regimens (p < 0.001). Genetic analyses did not display statistically significant effects on weight loss. No significant differences in weight loss were observed between macronutrient groups, aligning with the POUNDS Lost and DIETFITS studies. This study underscores the importance of dietary interventions for weight loss and the potential contributions of genetic makeup. These findings contribute to obesity management within the Greek population and support the need for further research in personalized interventions.